ETON PHARMACEUTICALS INC. - COMMON STOCK
20.01
27-مايو-25 12:38:45
15 متأخرة بدقائق
الأسهم
+0.20
+1.01%
نطاق اليوم
19.81 - 20.43
ISIN
N/A
المصدر
NASDAQ
-
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
11 مايو 2023 13:01:01 بحسب Nasdaq GlobeNewswire
-
10 مايو 2023 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
03 مايو 2023 13:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
16 مارس 2023 13:01:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
15 مارس 2023 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
07 مارس 2023 13:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
11 يناير 2023 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
10 نوفمبر 2022 13:05:01 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
02 نوفمبر 2022 13:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
18 أكتوبر 2022 03:50:00 بحسب Nasdaq GlobeNewswire
-
13 سبتمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
30 أغسطس 2022 13:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
11 أغسطس 2022 13:01:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
02 أغسطس 2022 05:00:02 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)
18 يوليو 2022 04:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Hospital Products
24 يونيو 2022 04:30:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
12 مايو 2022 13:02:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
03 مايو 2022 13:02:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer
11 أبريل 2022 13:01:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection
11 أبريل 2022 04:30:00 بحسب Nasdaq GlobeNewswire